Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update.
Rizzo JD, Somerfield MR, Hagerty KL, Seidenfeld J, Bohlius J, Bennett CL, Cella DF, Djulbegovic B, Goode MJ, Jakubowski AA, Rarick MU, Regan DH, Lichtin AE; American Society of Clinical Oncology; American Society of Hematology. Rizzo JD, et al. Among authors: djulbegovic b. J Clin Oncol. 2008 Jan 1;26(1):132-49. doi: 10.1200/JCO.2007.14.3396. Epub 2007 Oct 22. J Clin Oncol. 2008. PMID: 17954713
Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology.
Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS; American Society of Clinical Oncology. American Society of Hematology. Rizzo JD, et al. Among authors: djulbegovic b. J Clin Oncol. 2002 Oct 1;20(19):4083-107. doi: 10.1200/JCO.2002.07.177. J Clin Oncol. 2002. PMID: 12351606
A unifying framework for improving health care.
Djulbegovic B, Bennett CL, Guyatt G. Djulbegovic B, et al. J Eval Clin Pract. 2019 Jun;25(3):358-362. doi: 10.1111/jep.13066. Epub 2018 Nov 21. J Eval Clin Pract. 2019. PMID: 30461136
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate.
Dorr DA, Burdon R, West DP, Lagman J, Georgopoulos C, Belknap SM, McKoy JM, Djulbegovic B, Edwards BJ, Weitzman SA, Boyle S, Tallman MS, Talpaz M, Sartor O, Bennett CL. Dorr DA, et al. Among authors: djulbegovic b. Clin Cancer Res. 2009 Jun 1;15(11):3850-5. doi: 10.1158/1078-0432.CCR-08-1811. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458059 Free PMC article.
Thrombotic thrombocytopenic purpura: gaining knowledge.
Bennett CL, Djulbegovic B. Bennett CL, et al. Among authors: djulbegovic b. Lancet Haematol. 2016 May;3(5):e210-1. doi: 10.1016/S2352-3026(16)30028-X. Epub 2016 Apr 16. Lancet Haematol. 2016. PMID: 27132693 No abstract available.
385 results